Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PacGenomics is a U.S.-based CLIA-certified and CAP-accredited clinical genetics and molecular diagnostics laboratory that provides reproductive genetic testing, infectious disease testing, clinical toxicology, DNA identity testing, sequencing services, and genetic counseling. The company appears to be focused on laboratory-developed and service-based diagnostics rather than therapeutics, with commercial operations centered on advanced molecular analysis for healthcare providers and patients. Its technical capabilities include next-generation sequencing, long-read sequencing, Sanger sequencing, PCR, LC-MS, laboratory automation, and spatial transcriptomics services. PacGenomics also offers preimplantation genetic testing and has expanded into environmental PFAS testing, indicating a broader analytical testing business built on genomics and mass spectrometry infrastructure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PacGenomics.